[Susceptibility of clinical isolates against cefotiam, cefmenoxime, and cefsulodin: comparative study between MS-2 clinical system and disc agar method].
Honda
I
I
Ishimori
A
A
Kano
T
T
Sato
N
N
D001419:Bacteria / Q000187:drug effects*; D015281:Cefmenoxime; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D015310:Cefotiam; D002441:Cefsulodin / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests / Q000379:methods*
D015310:Cefotiam; D015281:Cefmenoxime; D002439:Cefotaxime; D002441:Cefsulodin